CSL Limited News - CSL

Is A$100 a Share Cursed? -- Market Talk

24:02 GMT [Dow Jones] When biopharmaceuticals company CSL (CSL.AU) shares earlier this month topped the A$100 mark, it generated a flurry of...

Australian Shares End Higher, Helped by Earnings and Sales Data

By Robb M. Stewart MELBOURNE, Australia--Australian stocks shrugged off a slump in oil prices to rise Tuesday, lifted by financial and...

Australia Shares End Slightly Down; Energy Stocks Rise

By Robb M. Stewart MELBOURNE, Australia--Australian stocks ended a volatile session slightly lower Tuesday, though a second day of gains by energy...

CSL Says CFO Naylor to Lead Influenza-Vaccine Business

By Robb M. Stewart MELBOURNE, Australia--CSL Ltd.'s (CSL.AU) chief financial officer is set to take the reins of the specialty biopharmaceutical...

What do rising U.S. interest rates mean for Australian companies?

http://www.fool.com.au/2015/03/17/what-do-rising-u-s-interest-rates-mean-for-australian-companies/

CSL Shaves Guidance as Competition Heats Up-- Update

By Rebecca Thurlow SYDNEY-- CSL Ltd., Australia's largest pharmaceutical company, warned rising competition in the blood-plasma-therapies market...

CSL Issues "Our Corporate Responsibility 2014" Report

CSL Issues "Our Corporate Responsibility 2014" Report Led by CSL Behring performance, the company focuses on sustainable business...

Drooping Commodities Hurt Down Under -- Barron's Asia

By Thomas Streater What a shocker! If you need a reason for why the Australian dollar and interest rates are likely to remain under pressure, then...

CMS Extends New Technology Add-On Payment for CSL Behring's Kcentra®

CMS Extends New Technology Add-On Payment for CSL Behring's Kcentra® Designation Helps Improve Patient Access to Kcentra in the Inpatient...

Evidence presented at the 16th Biennial Meeting of the European Society for Immunodeficiencies (ESID) Supports Individualized...

Evidence presented at the 16th Biennial Meeting of the European Society for Immunodeficiencies (ESID) Supports Individualized Dosing with...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CSL Limited (CSL)

Empower your portfolio: Real-time discussions and actionable trading ideas.

CSL News

Is A$100 a Share Cursed? -- Market Talk

Australian Shares End Higher, Helped by Earnings and Sales Data

Australia Shares End Slightly Down; Energy Stocks Rise

CSL Says CFO Naylor to Lead Influenza-Vaccine Business

What do rising U.S. interest rates mean for Australian companies?

CSL Shaves Guidance as Competition Heats Up-- Update

CSL Issues "Our Corporate Responsibility 2014" Report

Drooping Commodities Hurt Down Under -- Barron's Asia

CMS Extends New Technology Add-On Payment for CSL Behring's Kcentra®

Evidence presented at the 16th Biennial Meeting of the European Society for Immunodeficiencies (ESID) Supports Individualized...

CSL Behring Announces Winners of its 13th Annual Gettin' in the Game(SM) Junior National Championship Program

CSL Behring Signs Strategic Development Agreement With Enable Injections To Market Novel New Drug Delivery Device

CSL Behring Signs Strategic Development Agreement With Enable Injections To Market Novel New Drug Delivery Device

CSL to acquire Novartis' influenza vaccine business

CSL to Buy Novartis Influenza-Vaccine Unit

CSL Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CSL Limited (CSL) News

CSL Limited (CSL)

Empower your portfolio: Real-time discussions and actionable trading ideas.

CSL News

Is A$100 a Share Cursed? -- Market Talk

Australian Shares End Higher, Helped by Earnings and Sales Data

Australia Shares End Slightly Down; Energy Stocks Rise

CSL Says CFO Naylor to Lead Influenza-Vaccine Business

What do rising U.S. interest rates mean for Australian companies?

CSL Shaves Guidance as Competition Heats Up-- Update

CSL Issues "Our Corporate Responsibility 2014" Report

Drooping Commodities Hurt Down Under -- Barron's Asia

CMS Extends New Technology Add-On Payment for CSL Behring's Kcentra®

Evidence presented at the 16th Biennial Meeting of the European Society for Immunodeficiencies (ESID) Supports Individualized...

CSL Behring Announces Winners of its 13th Annual Gettin' in the Game(SM) Junior National Championship Program

CSL Behring Signs Strategic Development Agreement With Enable Injections To Market Novel New Drug Delivery Device

CSL Behring Signs Strategic Development Agreement With Enable Injections To Market Novel New Drug Delivery Device

CSL to acquire Novartis' influenza vaccine business

CSL to Buy Novartis Influenza-Vaccine Unit

CSL Discussion

Your Recent History